ICU
Price
$2.98
Change
-$0.21 (-6.58%)
Updated
Aug 5, 04:10 PM (EDT)
Capitalization
12.85M
13 days until earnings call
Intraday BUY SELL Signals
UNCY
Price
$5.22
Change
+$0.05 (+0.97%)
Updated
Aug 5, 04:59 PM (EDT)
Capitalization
141.48M
12 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ICU vs UNCY

ICU vs UNCY Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
ICU vs. UNCY commentary
Aug 05, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ICU is a Hold and UNCY is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 05, 2026
Stock price -- (ICU: $3.19 vs. UNCY: $5.17)
Brand notoriety: ICU and UNCY are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ICU: 67% vs. UNCY: 37%
Market capitalization -- ICU: $12.85M vs. UNCY: $141.48M
ICU [@Biotechnology] is valued at $12.85M. UNCY’s [@Biotechnology] market capitalization is $141.48M. The market cap for tickers in the [@Biotechnology] industry ranges from $121.26B to $0. The average market capitalization across the [@Biotechnology] industry is $2.1B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ICU’s FA Score shows that 1 FA rating(s) are green whileUNCY’s FA Score has 0 green FA rating(s).

  • ICU’s FA Score: 1 green, 4 red.
  • UNCY’s FA Score: 0 green, 5 red.
According to our system of comparison, both ICU and UNCY are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ICU’s TA Score shows that 5 TA indicator(s) are bullish while UNCY’s TA Score has 5 bullish TA indicator(s).

  • ICU’s TA Score: 5 bullish, 6 bearish.
  • UNCY’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, UNCY is a better buy in the short-term than ICU.

Price Growth

ICU (@Biotechnology) experienced а -7.27% price change this week, while UNCY (@Biotechnology) price change was +4.66% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.42%. For the same industry, the average monthly price growth was -6.62%, and the average quarterly price growth was +2896.47%.

Reported Earning Dates

ICU is expected to report earnings on Aug 18, 2026.

UNCY is expected to report earnings on Aug 17, 2026.

Industries' Descriptions

@Biotechnology (+4.42% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
UNCY($141M) has a higher market cap than ICU($12.9M). ICU YTD gains are higher at: 32.917 vs. UNCY (-10.399). ICU has higher annual earnings (EBITDA): -11.87M vs. UNCY (-39.24M). UNCY has more cash in the bank: 54.6M vs. ICU (9.35M). ICU has less debt than UNCY: ICU (331K) vs UNCY (941K). ICU has higher revenues than UNCY: ICU (1.44M) vs UNCY (0).
ICUUNCYICU / UNCY
Capitalization12.9M141M9%
EBITDA-11.87M-39.24M30%
Gain YTD32.917-10.399-317%
P/E RatioN/AN/A-
Revenue1.44M0-
Total Cash9.35M54.6M17%
Total Debt331K941K35%
TECHNICAL ANALYSIS
Technical Analysis
ICUUNCY
RSI
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 3 days ago
75%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
88%
Momentum
ODDS (%)
Bearish Trend 2 days ago
78%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
62%
Bullish Trend 2 days ago
88%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
82%
Bullish Trend 2 days ago
86%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 15 days ago
77%
Bullish Trend 2 days ago
83%
Declines
ODDS (%)
Bearish Trend 6 days ago
88%
Bearish Trend 8 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
56%
Bullish Trend 6 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
54%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
ICU
Daily Signal:
Gain/Loss:
UNCY
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VYGR3.120.12
+4.17%
Voyager Therapeutics
TNL78.061.02
+1.32%
Travel + Leisure Co
PBM3.190.04
+1.27%
Psyence Biomedical Ltd.
BBSI40.080.23
+0.58%
Barrett Business Services Inc.
ABEV3.04-0.01
-0.33%
Ambev SA

ICU and

Correlation & Price change

A.I.dvisor indicates that over the last year, ICU has been closely correlated with CANF. These tickers have moved in lockstep 92% of the time. This A.I.-generated data suggests there is a high statistical probability that if ICU jumps, then CANF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ICU
1D Price
Change %
ICU100%
-0.16%
CANF - ICU
92%
Closely correlated
+0.63%
APVO - ICU
91%
Closely correlated
+2.00%
GNPX - ICU
90%
Closely correlated
-6.95%
MLEC - ICU
86%
Closely correlated
+3.90%
TNXP - ICU
77%
Closely correlated
+5.11%
More